
Overview
Synektik Pharma Sp. z o.o. is part of the Synektik Group. The Group provides medical facilities with medical technologies, robotics, radiopharmaceuticals and IT solutions.
- al. Roździeńskiego 188c, 40-203 Katowice
- ul. Szaserów 128, 04-349 Warszawa
- ul. Artwińskiego 3, 25-734 Kielce
- ul. Keramzytowa 16, 96-320 Mszczonów
Financials
Revenue history (in m)
From the notes
| Profit allocation | Dividend and reserves | |
| Loans and borrowings | $0 | |
| Capital expenditure | $287,105 | |
| Planned capital expenditure (next year) | $376,695 | |
| Foreign sales | 2.34% of revenue ($303,388) | |
| Revenue structure | Sprzedaż radiofarmaceutyków – produkty i usługi |
Filing timeliness
Financial statements were filed on time, on average 47 days early. 5 of 6 audited by a statutory auditor.
- 202530/03/2026
- 202417/03/2025
- 202319/02/2024
- 202227/03/2023
- 202125/02/2022
- 202026/03/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
News
Industry
Offer
- Surgical robots
- Medical imaging equipment
- Radiopharmaceuticals
- Medical software
- CO2 injectors
- Histotripsy systems
- Endometrial ablation kits
- Densitometers
Websites
The site is available in: Polish, English and cz.
- synektik.com.plTechnologie medyczne i innowacje – SynektikWordPress 7.1Google AnalyticsGoogle Tag ManagerYoast SEOCloudflare
Public procurement
73 tenders recorded as contractor: 34 national ($4,387,779) and 39 EU ($15,707,163).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 26, 2026 | Supply of medicinal products and radiopharmaceuticals | $526.9K$526,883 | Zagłębiowskie Centrum Onkologii Szpital Specjalistyczny Im. Sz. Starkiewicza w Dąbrowie Górniczej | |
| Oct 8, 2026 | Emergency purchase of 18F-FDG radiopharmaceutical for PET examinations for Zakład Medycyny Nuklearnej z Ośrodkiem PET Świętokrzyskie Centrum Onkologii in Kielce. IZP.2411.197.2026.AJ | –– | Świętokrzyskie Centrum Onkologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Kielcach | |
| Sep 29, 2026 | Supply of radioisotope materials | $21,340$21,340 | Mazowiecki Szpital Wojewódzki Im. Św. Jana Pawła II w Siedlcach sp. z o.o. |
The company is the contractor in 12 public sector contracts, worth USD 1.47m in total. They were signed with 6 public buyers. The largest number (4) were signed with Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 9, 2026 | Synektik Pharma Spółka z ograniczoną odpowiedzialnością | $302,445 | Uniwersytecki Szpital Kliniczny Nr 4 w Lublinie | |
| Oct 28, 2026 | Supply of 18F-DCFPyl (piflufolastat 18F) for UCK. | $405,186 | Uniwersyteckie Centrum Kliniczne | |
| Sep 23, 2026 | Supply of radiopharmaceuticals | $14,911 | 5 Wojskowy Szpital Kliniczny z Polikliniką-Samodzielny Publiczny Zakład Opieki Zdrowotnej w Krakowie |
Synektik Pharma has been a party to 1 case before the National Appeal Chamber (since 2022). In 1 case it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Jun 14, 2022 | Order | Authority accepted the complaints | Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii |
Job offers
The company lists 6 job openings on its own careers page: synektik.com.pl/category/kariera.
Authorized Representatives
Manner of representation
In the case of a one-person management board, each member of the management board acting independently. In the case of a multi-member management board, the President of the Management Board independently, or two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 201 | $2,714.75 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2011-09-14.
38 1030 1508 0000 0008 2263 0001
63 1090 1056 0000 0001 4265 4580
42 1090 1056 0000 0001 4265 4667
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $98,810$98,810 |
Buildings and premises | $1.5M$1,475,180 |
Public aid
7 public aid cases recorded, with a total value of $870,982.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $11,158$11,158 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $11,568$11,568 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $11,060$11,060 | Prezes Zakładu Ubezpieczeń Społecznych |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2018-10-01 | Development of Synektik Pharma’s research and development facilities to develop new specialized radiopharmaceuticals for targeted oncological and neurological diagnostics using positron emission tomography (PET) | $428.7K$428,663 | Operational Programme Smart Growth | |
| 2018-06-01 | Market launch of a new radiopharmaceutical, 18F-fluorothymidine (FLT), for targeted cancer diagnostics and assessment of treatment progress. | $227.6K$227,581 | Operational Programme Smart Growth |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Intimex sp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Nova Group A. Chmielewski sp. k. | $12,556,899.57 | novagroup.pl | ||
| Polymed Polska sp. z o.o. | $12,057,904.38 | polymed.com.pl | ||
| Timko sp. z o.o. | $11,816,633.86 | timko.com.pl | ||
| P.A.D. Technologies Ltd sp. z o.o. | $11,700,404.26 | padtech.pl | ||
| Solve Medical sp. z o.o. | $9,171,826.22 | solvemedical.pl | ||
| Binatural Krystosiak sp. k. | $8,219,823.18 | binatural.pl | ||
| Shar-POL sp. z o.o. | $7,349,849.67 | shar-pol.pl | ||
| Meditrade Poland sp. z o.o. | $1,940,256.95 | meditrade.com.pl | ||
| Medico Systems sp. z o.o. | $1,647,640.58 | medicosystems.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-08-12 | Address change (Aleja Wincentego Witosa 31, 00-710, Warszawa → Ul. Józefa Piusa Dziekońskiego 3, 00-728, Warszawa) | |
| 2018-08-24 | Share capital reduction (10,500.00 PLN → 10,050.00 PLN) | |
| 2018-07-04 | Share capital increase (5,050.00 PLN → 10,500.00 PLN) | |
| 2018-05-10 | Address change (Piękna 15/12, 00-549, Warszawa → Aleja Wincentego Witosa 31, 00-710, Warszawa) | |
| 2018-05-10 | Name change (Monrol Poland Ltd → Synektik Pharma) |
FAQ
Last updated: 2026-10-07
![2026 – Development of a generic drug – a radiopharmaceutical product with the active substance 6-[18F]fluorolevodopa for PET diagnostics](https://synektik.com.pl/wp-content/uploads/2026/11/image.png)

